Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9292585 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity
Condition: HIV Infections
Intervention: Biological: gp160 Vaccine (MicroGeneSys)

Indicates status has not been verified in more than two years